These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29455869)

  • 21. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy.
    Ding H; Gui X; Lin X; Chen R; Ma T; Sheng Y; Cai H; Fen Y
    Technol Cancer Res Treat; 2017 Oct; 16(5):645-653. PubMed ID: 27688262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer.
    Gao L; Zhang H; Zhang B; Zhu J; Chen C; Liu W
    J Clin Pathol; 2018 Jul; 71(7):642-647. PubMed ID: 29483137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival.
    Bonin S; Pracella D; Barbazza R; Sulfaro S; Stanta G
    Virchows Arch; 2015 May; 466(5):571-80. PubMed ID: 25724181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.
    Sulzer MA; Leers MP; van Noord JA; Bollen EC; Theunissen PH
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1319-23. PubMed ID: 9563756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
    Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
    Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of deoxyribonucleic acid aneuploidy in primary non-small-cell lung carcinomas and their metastases.
    Liewald F; Hatz R; Storck M; Orend KH; Weiss M; Wulf G; Valet G; Sunder-Plassmann L
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1476-82. PubMed ID: 1331622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
    Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
    Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer.
    Tran TN; Selinger CI; Yu B; Ng CC; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    J Clin Pathol; 2014 Nov; 67(11):985-91. PubMed ID: 25118293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer.
    Qiu ZX; Zhao S; Mo XM; Li WM
    Int J Clin Exp Pathol; 2015; 8(6):6589-95. PubMed ID: 26261540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
    Paulsen EE; Kilvaer TK; Rakaee M; Richardsen E; Hald SM; Andersen S; Busund LT; Bremnes RM; Donnem T
    Cancer Immunol Immunother; 2017 Nov; 66(11):1449-1461. PubMed ID: 28707078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
    Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
    J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer.
    Huang F; Zhao Y; Zhao J; Wu S; Jiang Y; Ma H; Zhang T
    Int J Clin Exp Pathol; 2014; 7(9):6006-14. PubMed ID: 25337245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of the current Japanese nodal classification on outcomes in resected non-small cell lung cancer.
    Ichinose J; Murakawa T; Hino H; Konoeda C; Inoue Y; Kitano K; Nagayama K; Nitadori JI; Anraku M; Nakajima J
    Chest; 2014 Sep; 146(3):644-649. PubMed ID: 24811857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.